[go: up one dir, main page]

BR9908960A - Cyclic guanidine amino - Google Patents

Cyclic guanidine amino

Info

Publication number
BR9908960A
BR9908960A BR9908960-2A BR9908960A BR9908960A BR 9908960 A BR9908960 A BR 9908960A BR 9908960 A BR9908960 A BR 9908960A BR 9908960 A BR9908960 A BR 9908960A
Authority
BR
Brazil
Prior art keywords
cyclic guanidine
cyclic
amino
guanidine amino
substituents
Prior art date
Application number
BR9908960-2A
Other languages
Portuguese (pt)
Inventor
Gerd Ascher
Werner Heilamayer
Johannes Ludescher
Johannes Hilderbrandt
Michael Schranz
Josef Wieser
Original Assignee
Biochemie Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biochemie Gmbh filed Critical Biochemie Gmbh
Publication of BR9908960A publication Critical patent/BR9908960A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Patente de Invenção: <B>"AMINO GUANIDINAS CìCLICAS"<D>. Composto de fórmula onde R~ 2~ juntamente com o átomo de nitrogênio ao qual ele está ligado forma um grupo aminoguanidino cíclico ou derivado do mesmo, sendo que os outros substituintes possuem vários significados, útil como produto farmacêutico.Invention Patent: <B> "AMINO CYCLIC GUANIDINES" <D>. Compound of formula where R ~ 2 ~ together with the nitrogen atom to which it is attached forms a cyclic or derivative aminoguanidine group, the other substituents having several meanings, useful as a pharmaceutical product.

BR9908960-2A 1998-03-23 1999-03-19 Cyclic guanidine amino BR9908960A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0051598A AT406772B (en) 1998-03-23 1998-03-23 ANTIBACTERIAL 7-ACYLAMINO-3-IMINOMETHYL-CEPHALOSPORINE AND METHOD FOR THE PRODUCTION THEREOF
PCT/EP1999/001853 WO1999048896A1 (en) 1998-03-23 1999-03-19 Cephalosporines having cyclic aminoguanidine substituents as antibiotics

Publications (1)

Publication Number Publication Date
BR9908960A true BR9908960A (en) 2000-12-05

Family

ID=3492649

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9908960-2A BR9908960A (en) 1998-03-23 1999-03-19 Cyclic guanidine amino

Country Status (25)

Country Link
US (1) US6440957B1 (en)
EP (2) EP1930335A1 (en)
JP (1) JP2002507616A (en)
KR (1) KR100696422B1 (en)
CN (1) CN1188418C (en)
AR (1) AR015248A1 (en)
AT (1) AT406772B (en)
AU (1) AU749735B2 (en)
BR (1) BR9908960A (en)
CA (1) CA2324953C (en)
CO (1) CO5080739A1 (en)
HU (1) HUP0101603A3 (en)
ID (1) ID26567A (en)
IL (2) IL138477A0 (en)
MY (1) MY119841A (en)
NO (1) NO20004760L (en)
NZ (1) NZ506908A (en)
PE (1) PE20000360A1 (en)
PL (1) PL343094A1 (en)
RU (1) RU2245884C2 (en)
SK (1) SK14152000A3 (en)
TR (1) TR200002749T2 (en)
TW (1) TWI250983B (en)
WO (1) WO1999048896A1 (en)
ZA (1) ZA200004850B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020115852A1 (en) * 1997-04-01 2002-08-22 Gerd Ascher Antibacterial substituted 7-acylamino-3-(methylhydrazono) methyl-cephalosporins and intermediates
DE102007052891A1 (en) 2007-11-02 2009-05-07 Evonik Degussa Gmbh Process for the stabilization of olefinically unsaturated monomers
DE102013204950A1 (en) 2013-03-20 2014-09-25 Evonik Industries Ag Process and composition for inhibiting the polymerization of cyclopentadiene compounds
EP2993164B1 (en) 2014-09-08 2017-02-15 Evonik Degussa GmbH Phenolic (thio) acetals as inhibitors of the polymerisation of olefinically unsaturated monomers
TWI669317B (en) 2014-09-22 2019-08-21 德商贏創德固賽有限責任公司 Method for improved reactive monomer production

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE943408C (en) * 1953-03-31 1956-05-17 Bayer Ag Process for the preparation of bisguanylhydrazones
FI851934A7 (en) * 1984-05-30 1985-12-01 Ici Plc Cephalosporin derivatives.
GB8721568D0 (en) * 1987-09-14 1987-10-21 Fujisawa Pharmaceutical Co Cephem compounds
PL193133B1 (en) * 1995-05-11 2007-01-31 Sandoz Ag Antibacterial cephalosporins
NZ337732A (en) * 1997-04-01 2001-09-28 Biochemie Gmbh Antibacterial substituted 7-acylamino -3-(methylhydrazono) methyl-cephalosporins and intermediates

Also Published As

Publication number Publication date
CA2324953C (en) 2008-05-13
ID26567A (en) 2001-01-18
PL343094A1 (en) 2001-07-30
NZ506908A (en) 2003-04-29
EP1930335A1 (en) 2008-06-11
JP2002507616A (en) 2002-03-12
TR200002749T2 (en) 2000-12-21
ATA51598A (en) 2000-01-15
MY119841A (en) 2005-07-29
IL138477A (en) 2007-06-17
AU749735B2 (en) 2002-07-04
AU3518899A (en) 1999-10-18
RU2245884C2 (en) 2005-02-10
WO1999048896A1 (en) 1999-09-30
KR100696422B1 (en) 2007-03-20
CN1294593A (en) 2001-05-09
CN1188418C (en) 2005-02-09
CA2324953A1 (en) 1999-09-30
TWI250983B (en) 2006-03-11
IL138477A0 (en) 2001-10-31
HUP0101603A3 (en) 2002-10-28
US6440957B1 (en) 2002-08-27
ZA200004850B (en) 2002-02-27
CO5080739A1 (en) 2001-09-25
NO20004760L (en) 2000-11-21
AR015248A1 (en) 2001-04-18
HUP0101603A2 (en) 2001-12-28
AT406772B (en) 2000-08-25
KR20010074666A (en) 2001-08-08
EP1082326A1 (en) 2001-03-14
NO20004760D0 (en) 2000-09-22
SK14152000A3 (en) 2001-05-10
PE20000360A1 (en) 2000-05-17

Similar Documents

Publication Publication Date Title
BR0012880A (en) Mutilin derivatives and their use as antibacterials
NO20020725L (en) cell adhesion inhibitor
HUP9802859A2 (en) Acylaminosalicylic acid amides and their uses as pesticides
CY1120169T1 (en) AMIDIUM PRODUCT AND DRUG
BR9907429A (en) Hydrazide compound, process for its preparation and pharmaceutical compositions containing the same
BR9900443A (en) Acrylic aryl acid esters.
UA39099C2 (en) CYCLIC NITROGEN-CONTAINING DERIVATIVES, A MIXTURE OF THEIR ISOMERS OR INDIVIDUAL ISOMERS OR THEIR SALTS
BR9916328A (en) Farnesyl transferase inhibitors
ATE316531T1 (en) CONDENSED DIHYDROCINOLINONE DERIVATIVES FOR INHIBITING MRP1
WO2005002508A3 (en) Macromolecular platinum chelates
BR9805031A (en) Naphthalene compounds, process for their preparation and pharmaceutical compositions containing them.
DE69208408D1 (en) Phenylthiourea derivatives and their pharmaceutical use
HUP0201475A2 (en) Heteroaryl amidines, methylamidines and guanidines their preparation and use and pharmaceutical compositions containing them
BR9908960A (en) Cyclic guanidine amino
HRP20070286T3 (en) Substituted diketopiperazines and their use as oxytocyn antagonists
DE69915514D1 (en) Prenyl INHIBITORS
BR0000158A (en) Cyanoindole serotonin reabsorption inhibitor compounds, process for their preparation and pharmaceutical compositions containing the same
DE602004025935D1 (en) HISTONDEACETYLASEINHIBITOR AND METHOD FOR THE PRODUCTION THEREOF
MY129094A (en) Condensed polycyclic compounds
DE60119383D1 (en) FARNESYL TRANSFERASE-INHIBITING 4-HETEROCYCLYLCHINOLIN AND CHINAZOLINE DERIVATIVES
BR0112849A (en) Process for the preparation of a chiral compound, and chiral compound
BR0312698A (en) Cephalosporins
EA200000829A1 (en) METHODS AND INTERMEDIATE PRODUCTS USEFUL FOR OBTAINING ANTIFOLATES
NO20060884L (en) Adhesive composition comprising a formaldehyde-containing aminoplast resin and a catalyzing compound
BR0312719A (en) Compounds, processes for obtaining carbamates and non-phosphorylated derivatives and amidoxime derivatives, pharmaceutical compositions, and use of at least one compound

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: C07D 501/46, A61K 31/545, A61P 31/04

Ipc: C07D 501/46 (2009.01), A61K 31/545 (2009.01)

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE ACORDO COM OS ARTIGOS 8O, 10 (VIII), 11, 13, 24 E 25 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.